BE693079A - - Google Patents

Info

Publication number
BE693079A
BE693079A BE693079DA BE693079A BE 693079 A BE693079 A BE 693079A BE 693079D A BE693079D A BE 693079DA BE 693079 A BE693079 A BE 693079A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE693079A publication Critical patent/BE693079A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE693079D 1966-01-25 1967-01-24 BE693079A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52282966A 1966-01-25 1966-01-25

Publications (1)

Publication Number Publication Date
BE693079A true BE693079A (zh) 1967-07-24

Family

ID=24082557

Family Applications (1)

Application Number Title Priority Date Filing Date
BE693079D BE693079A (zh) 1966-01-25 1967-01-24

Country Status (14)

Country Link
US (1) US3459763A (zh)
AT (1) AT262997B (zh)
BE (1) BE693079A (zh)
CH (1) CH474522A (zh)
DE (1) DE1695005A1 (zh)
DK (1) DK121302B (zh)
ES (1) ES336020A1 (zh)
FR (2) FR1508888A (zh)
GB (1) GB1131191A (zh)
GR (1) GR36359B (zh)
IL (1) IL27312A (zh)
NL (1) NL6701100A (zh)
NO (1) NO117129B (zh)
SE (1) SE339475B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700685A (en) * 1970-05-15 1972-10-24 Merck & Co Inc Nitroimidazole derivatives
US3859302A (en) * 1973-02-05 1975-01-07 Monsanto Co Preparation of 2-imino-imidazole derivatives
FR2269341B1 (zh) * 1974-04-30 1978-07-28 Castaigne Sa
US4289778A (en) * 1977-12-27 1981-09-15 Eli Lilly And Company 2-(Substituted imino)-N-(3-substituted phenyl)-3-thiazolidinecarbothioamides
EP0656210A1 (en) * 1993-11-19 1995-06-07 Takeda Chemical Industries, Ltd. Imidazole derivatives as glutaminose inhibitors
EP0741709B1 (en) * 1994-01-24 2001-07-25 Allergan Sales, Inc. Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6087361A (en) * 1995-05-12 2000-07-11 Allergan Sales, Inc. Aryl-imidazolines and aryl-imidazoles useful as α-2 adrenergic agonists without cardiovascular side effects
CN1411449A (zh) * 1999-12-17 2003-04-16 宝洁公司 N－(1－苯乙基)－5－苯基－咪唑－2－胺化合物,它们的组合物和应用
US6596739B2 (en) 2000-03-29 2003-07-22 The Procter & Gamble Company N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses
US20050054705A1 (en) 2003-02-04 2005-03-10 Aventis Pharma Deutschland Gmbh N-substituted (benzoimidazol-2-yl) phenylamines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
DE10304374A1 (de) * 2003-02-04 2004-08-05 Aventis Pharma Deutschland Gmbh Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
AU2007332641A1 (en) 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag Novel 2 -imidazoles as ligands for trace amine associated receptors (TAAR)
WO2009003868A2 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
EP2183216A1 (en) 2007-07-27 2010-05-12 F. Hoffmann-Roche AG 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
CN101784515A (zh) 2007-08-03 2010-07-21 弗·哈夫曼-拉罗切有限公司 作为taar1配体的吡啶甲酰胺和苯甲酰胺衍生物
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
CR20180443A (es) 2016-03-17 2018-11-21 Hoffmann La Roche Derivado de morfolina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2988478A (en) * 1958-12-22 1961-06-13 Pfizer & Co C Agricultural compositions and use

Also Published As

Publication number Publication date
GB1131191A (en) 1968-10-23
IL27312A (en) 1971-01-28
SE339475B (zh) 1971-10-11
ES336020A1 (es) 1967-12-16
AT262997B (de) 1968-07-10
CH474522A (de) 1969-06-30
GR36359B (el) 1969-02-03
NO117129B (zh) 1969-07-07
FR1508888A (fr) 1968-01-05
US3459763A (en) 1969-08-05
DE1695005A1 (de) 1971-02-25
FR6337M (zh) 1968-09-30
DK121302B (da) 1971-10-04
NL6701100A (zh) 1967-07-26

Similar Documents

Publication Publication Date Title
FR6337M (zh)
AT281852B (zh)
AU5917865A (zh)
AU428063B2 (zh)
AU1141566A (zh)
AU433222B2 (zh)
AU414526B2 (zh)
AU417216B2 (zh)
AU415165B1 (zh)
AU6703465A (zh)
AU218666A (zh)
AU1111066A (zh)
AU612166A (zh)
AU1144366A (zh)
AU1393566A (zh)
AU5895065A (zh)
AU411645B2 (zh)
AU415780B2 (zh)
AU6852465A (zh)
AU855865A (zh)
AU92366A (zh)
AU407778B2 (zh)
BE691285A (zh)
AU414093B2 (zh)
BE284991A (zh)